HIT
Health In Tech, Inc.NASDAQTechnology$1.44+1.41%ClosedMarket Cap: $77.6M
As of 2026-04-06
Valuation
P/E (TTM)
60.65
PEG
0.67
P/B
4.60
P/S
2.28
EV/EBITDA
26.57
DCF Value
$-0.19
FCF Yield
-6871959.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
62.8%
Operating Margin
4.6%
Net Margin
3.8%
ROE
7.9%
ROA
5.5%
ROIC
6.5%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $7.5M | 55.0% | $-170.8K | $-302.6K | $-0.01 | — |
| FY 2025 | $33.3M | 62.8% | $1.5M | $1.3M | $0.02 | — |
| Q3 2025 | $8.5M | 60.6% | $493.5K | $452.2K | $0.01 | — |
| Q2 2025 | $9.3M | 67.7% | $725.1K | $630.6K | $0.01 | — |
| Q1 2025 | $8.0M | 66.8% | $480.7K | $498.6K | $0.01 | — |
| Q4 2024 | $4.9M | 77.4% | $-316.3K | $-144.2K | $-0.00 | — |
| FY 2024 | $19.5M | 79.2% | $989.9K | $670.5K | $0.01 | — |
| Q3 2024 | $4.5M | 78.0% | $438.9K | $376.1K | $0.01 | — |
| Q2 2024 | $5.0M | 80.5% | $534.9K | $338.0K | $0.01 | — |
| Q1 2024 | $5.1M | 80.7% | $332.4K | $100.5K | $0.00 | — |
| Q4 2023 | $5.2M | 81.8% | $1.5M | $1.0M | $0.02 | — |
| FY 2023 | $19.2M | 88.0% | $3.4M | $2.5M | $0.05 | — |